17 results on '"Dalgard O"'
Search Results
2. SAT-163 - C-Edge Co-Star: Risk of Reinfection following Successful Therapy with Elbasvir and Grazoprevir in Persons who Inject Drugs (PWID) Receiving Opioid Agonist Therapy (OAT)
3. FRI-195 - Hepatitis C Virus Core Antigen: A Simplified Treatment Monitoring Tool, including for Post-Treatment Relapse
4. P0848 : Efficacy of response-guided pegylated interferon and ribavirin therapy for people who inject drugs with HCV genotype 2/3 infection: The activate study
5. P0842 : Malachite-I: Phase 3B Trial of ombitasvir/paritaprevir/r and dasabuvir +/− ribavirin or telaprevir + peginterferon/ribavirin in treatment-naïve adults with HCV genotype 1
6. Short-term treatment duration for HCV-2 and HCV-3 infected patients.
7. Hepatitis C infection in the general urban population: Prevalence and spectrum of disease
8. Short treatment (14 weeks) with pegylated interferon alpha-2B and ribavirin for the treatment of hepatitis C genotype 2/3 infection
9. LP49 : Sofosbuvir containing regimes to patients with HCV genotype 3 infection. A scandinavian real-life experience.
10. 412 THE USEFULNESS OF DEFINING RVR BY A VERY SENSITIVE ASSAY DURING THE TREATMENT OF HCV GENOTYPE 3 INFECTION; A COMPARISON OF TMA AND AMPLICOR
11. 411 ADHERENCE TO EVIDENCE-BASED GUIDELINES IN THE TREATMENT OF HCV GENOTYPE 2 OR 3 INFECTION. A REAL LIFE EXPERIENCE
12. 630 RIBAVIRIN (RBV) DOSAGE AS INDEPENDENT PREDICTOR OF RVR IN HCV GENOTYPE 2 (HCV-2) AND 3 (HCV-3) PATIENTS UNDERGOING COMBINED TREATMENT WITH PEG INTERFERON (PEG-IFN) ALPHA-2B
13. 728 IS SUSTAINED VIROLOGICAL RESPONSE TO HCV TREATMENT ASSOCIATED WITH A CLINICAL IMPORTANT IMPROVEMENT IN VITALITY?
14. [128] PEGINTERFERON o-2b AND RIBAVIRIN FOR 14 OR 24 WEEKS IN PATIENTS WITH HCV GENOTYPE 2 OR 3 AND RAPID VIROLOGICAL RESPONSE. THE NORTH-C TRIAL
15. 061 : Incidence of hepatitis C reinfection following sustained virological response – A seven year follow-up of scandinavian patients infected through injecting drug use.
16. P1214 RIBAVIRIN MONOTHERAPY REDUCES HCVRNA IN ASSOCIATION WITH IL28B GENOTYPE AND ALSO IP-10 CONCENTRATIONS AMONG PATIENTS INFECTED WITH HEPATITIS C GENOTYPE 1.
17. 1151 GENETIC VARIANTS AT ITPA THE LOCUS PROTECTS AGAINST RIBAVIRIN-INDUCED HEMOLYTIC ANEMIA – A REPLICATION STUDY IN A SCANDINAVIAN HCV G2/G3 COHORT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.